Company Analysis

Bone Biologics Corp (BBLG)

Nasdaq: BBLG · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Burlington, MA · filing with the SEC since 2008
Grade4.4
◀ Past 2.8● Present 5.2▶ Future 4.9
5 est.

Filings

264 filings since 2017 beside 67 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Aug 28, 2026.

Filings a yearinsider forms included
245333453593529
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Sep 16, 2026.Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest May 30, 2025.SEC letters: 13 in the last 36 months, the newest Aug 29, 2025.
Insider forms 67

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 26, 2026 10-Q Quarterly report Sep 30, 2026
Oct 13, 2026 25-NSE Delisting notice from the exchange
Sep 29, 2026 8-K item 5.07 Shareholder vote · Current report Sep 28, 2026
Sep 16, 2026 8-K item 3.01 Listing warning from its exchange · Current report Sep 10, 2026
Aug 28, 2026 DEF 14A Proxy statement
Aug 18, 2026 PRE 14A Preliminary proxy statement
Aug 14, 2026 10-Q Quarterly report Jun 30, 2026
Jul 24, 2026 EFFECT Registration effective
Jul 24, 2026 424B3 Shelf offering
Jul 23, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jul 20, 2026 DEFA14A Extra proxy material
Jul 17, 2026 S-3 Shelf registration
Jul 16, 2026 8-K item 8.01 Other event · Current report Jul 15, 2026
Jul 9, 2026 8-K items 1.01, 3.02, 8.01, 9.01 Major agreement signed; Shares sold without registration; Other event · Current report Jul 7, 2026
Jul 2, 2026 ARS Annual report to shareholders Dec 31, 2025
Jul 2, 2026 DEFA14A Extra proxy material
Jul 2, 2026 DEF 14A Proxy statement
May 14, 2026 10-Q Quarterly report Mar 31, 2026
Mar 13, 2026 8-K items 8.01, 9.01 Other event · Current report
Mar 13, 2026 424B5 Shelf offering
Mar 2, 2026 10-K Annual report Dec 31, 2025
Jan 8, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Nov 14, 2025 10-Q Quarterly report Sep 30, 2025
Nov 7, 2025 SCHEDULE 13G/A Large holder update, amended
Sep 26, 2025 S-8 Employee stock plan registration
Sep 4, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 2, 2025 EFFECT Registration effective
Aug 29, 2025 CORRESP Reply to the SEC
Aug 29, 2025 S-3/A Shelf registration, amended
Aug 14, 2025 10-Q Quarterly report Jun 30, 2025
Jul 3, 2025 SCHEDULE 13G Large holder notice
Jul 1, 2025 UPLOAD SEC comment letter
Jun 30, 2025 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Jun 27, 2025
Jun 30, 2025 424B4 Offering prospectus
Jun 27, 2025 EFFECT Registration effective
Jun 26, 2025 8-K items 8.01, 9.01 Other event · Current report Jun 25, 2025
Jun 24, 2025 CORRESP Reply to the SEC
Jun 24, 2025 S-3 Shelf registration
Jun 24, 2025 S-1 Listing registration
40 of 264 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton BBLG · research, not advice